generic drugs
Welcome to the 'generic drugs' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'generic drugs'.
Are you an expert about 'generic drugs'? Do you want to be the Technorati authority on 'generic drugs'? You can write a description that will appear right here:
Join Blogcritics!
Original Technorati articles tagged “generic drugs”
-
in BloggingNew Questions and Answers on Lipitor, the Most Prescribed Brand Name Drug in America

The Complicated Maneuverings That Happen When a Lucrative Drug Loses Its Patent Exclusivityby patmalone51 / on Jan 22, 2012 -
in LifestyleGeneric or Brand-Name Drugs?

Generic drugs, brand-name drugs, and the rising costs of medications: there are no easy answers or solutions for this healthcare battle.by livingwithaih / on Feb 9, 2010 -
in BusinessAllergan Victorious in Patent Infringement Lawsuit

District Court rules ALPHAGAN® P patents enforceable and infringed by Apotex and Exela.by ipwatchdog / on Oct 25, 2009
Latest blogosphere posts tagged “generic drugs”
-
Another Court Throws Generic Plaintiffs a Lifeline
Drug and Device Law —
Authority: 455
As evidenced by our generic preemption scorecard the post- Mensing scales have been heavily tipped in favor of the generic manufacturers who have racked up dismissals across the country. But not every court is willing to jump on the “complete dismissal” side of the seesaw. We ...1 week ago -
Is Pfizers Lipitor Strategy Working?
Drug Channels —
Authority: 100
Since November 30, the atorvastatin market has been split between Pfizer’s heavily-discounted brand-name Lipitor product, an authorized generic from Watson, and the first-to-file generic Ranbaxy. See Ranbaxy Makes Three: The Battle for Generic Lipitor Profits . Pfizer has been criticized for its unorthodox ...1 week ago -
FDA Completed Recommendatons for Three Drug User Fee Programs
Toonari Post - A News Mash Up! —
Authority: 441
The U.S. Food and Drug Administration has completed its recommendations for three user fee programs that will help speed safe and effective drugs and lower-cost generic drug and biosimilar biological products to patients, FDA Commissioner Margaret A. Hamburg, M.D. said on January 13. The recommendations were ...1 week ago -
Class Action Suit Accuses Walgreen, Par Pharmaceutical of Overcharging Conspiracy
Wall St. Cheat Sheet —
Authority: 603
A union benefits fund has filed a class-action lawsuit against Walgreen ( NYSE:WAG ) and Par Pharmaceutical Companies ( NYSE:PRX ) accusing them of having engaged in “at least two widespread schemes to overcharge” for generic drugs. Hot Feature: Agricultral Stocks Pop and Drop After USDA Report Walgreen ...2 weeks ago -
Novartis Cutting Close to 2000 Jobs in the US–Patent Loss for Diovan Attributed to Anticipated Loss of Sales Revenue
The Medical Quack —
Authority: 118
Novartis was also in the news for the recall of several over the counter drugs in the last week and has closed one factory in the US until corrections are made. Novartis Recalls of Excedrin and Other Over The Counter Drugs May Be Mixed Up Wit Opioid Pain Killers–So Where Are the Bar Codes to Help Consumers Find ...2 weeks ago -
Healthcare Investing in an Election Year: ABT, WNI, ISRG, MRGE, HITK
The Market Playground —
Authority: 463
By Bob Freedland 2011 was a challenging year for investors, and for the Healthcare model it was particularly difficult. Overall, the model finished the year with a 6.47% loss. I spent a lot of time during the year trying to identify the holdings in the Healthcare field that could perform well in spite of the [...]2 weeks ago -
Generic Drugs: Are they Equivalent?
Science-Based Medicine —
Authority: 538
With healthcare costs continuing to rise, generic drugs are looking more attractive than ever. The prospect of getting the same drug at a lower cost is tempting to anyone with a large drug bill – patient or insurer alike. The savings are massive: Lipitor lost patent protection last month – it was a $10 billion ...3 weeks ago



Follow Technorati